抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
TAK733抑制剂 | TAK-733 | 1035555-63-5 | C17H15F2IN4O4 |
|
TAK 285; N-[2-[4-[[3-氯-4-[3-(三氟甲基)苯氧基]苯基]氨基]-5H-吡咯并[3,2-d]嘧啶-5-基]乙基]-3-羟基-3-甲基丁酰胺 | TAK-285 | 871026-44-7 | C26H25ClF3N5O3 |
|
StemRegenin1抑制剂 | StemRegenin1 | 1227633-49-9 | C24H23N5OS |
|
Stat5抑制剂 | N'-[(4-oxo-4H-chromen-3-yl)methylene]isonicotinohydrazide | 285986-31-4 | C16H11N3O3 |
|
Scriptaid抑制剂 | scriptaid | 287383-59-9 | C18H18N2O4 |
|
Sb525334 6-[2-叔丁基-5-(6-甲基-吡啶-2-基)-1H-咪唑-4-基]-喹噁啉 | SB 525334 | 356559-20-1 | C21H21N5 |
|
SR 1078; N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]-4-(三氟甲基)苯甲酰胺 | SR1078 | 1246525-60-9 | C17H10F9NO2 |
|
SNX 2112; 2-[(反式-4-羟基环己基)氨基]-4-[4,5,6,7-四氢-6,6-二甲基-4-氧代-3-(三氟甲基)-1H-吲唑-1-基]苯甲酰胺 | 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((trans-4-hydroxycyclohexyl)amino)benzamide | 945626-71-1 | C23H27F3N4O3 |
|
SIRT1/SIRT2抑制剂(TENOVIN-6) | Tenovin-6 | 1011557-82-6 | C25H34N4O2S |
|
SGC0946抑制剂 | Sgc0946 | 1561178-17-3 | C28H40BrN7O4 |
|
SBE13盐酸盐 | SBE13 hydrochloride | 1052532-15-6 | C24H28Cl2N2O4 |
|
SB743921抑制剂 | (R)-N-(3-aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methylpropyl)-4-methylbenzamide hydrochloride | 618430-39-0 | C31H34Cl2N2O3 |
|
SB273005INTEGRIN抑制剂 | (4S)-2,3,4,5-tetrahydro-8-[2-[6-(methylamino)-2-pyridinyl]ethoxy]-3-oxo-2-(2,2,2-trifluoroethyl)-1H-2-benzazepine-4-acetic acid | 205678-31-5 | C22H24F3N3O4 |
|
S-鲁索替尼 | ruxolitinib | 941685-37-6 | C17H18N6 |
|
S- (+)-咯利普兰 | (S)-rolipram | 85416-73-5 | C16H21NO3 |
|
RN486抑制剂 | 6-cyclopropyl-8-fluoro-2-(2-hydroxymethyl-3-{1-methyl-5-[5-(4-methyl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-2H-isoquinolin-1-one | 1242156-23-5 | C35H35FN6O3 |
|
RACGTPASE抑制剂(EHOP-016) | EHop-016 | 1380432-32-5 | C25H30N6O |
|
R132H-IDH1抑制剂(AGI-5198) | AGI-5198 | 1355326-35-0 | C27H31FN4O2 |
|
PYR41抑制剂 | Ethyl 4-[4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl]benzoate | 418805-02-4 | C17H13N3O7 |
|
PVM/MA共聚物 | vorasidenib | 1644545-52-7 | C14H13ClF6N6 |
|
PPIase-Parvulin抑制剂 | 1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn][3,8]phenanthroline-2,7-diacetic acid 2,7-diethyl ester | 64005-90-9 | C22H18N2O8 |
|
PORCN酶活性和WNT抑制剂(WNT-C59) | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide | 1243243-89-1 | C25H21N3O |
|
POLO-LIKEKINASE1抑制剂 | GSK461364 | 929095-18-1 | C27H28F3N5O2S |
|
PND-1186游离态 | 2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide | 1061353-68-1 | C25H26F3N5O3 |
|
PLK1抑制剂(RO3280) | RO3280 | 1062243-51-9 | C27H35F2N7O3 |
|
PKI-402; 1-[4-[3-乙基-7-(吗啉-4-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-基]苯基]-3-[4-[(4-甲基哌嗪-1-基)羰基]苯基]脲 | PKI-402 | 1173204-81-3 | C29H34N10O3 |
|
PJ34盐酸盐 | 2-(Dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide hydrochloride | 344458-15-7 | C17H18ClN3O2 |
|
PHT 427; 4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 | ARC-183 | 1191951-57-1 | C20H31N3O2S2 |
|
PF03716556;8-[[(4R)-3,4-二氢-5-甲基-2H-1-苯并吡喃-4-基]氨基]-N-(2-羟基乙基)-N,2-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺 | N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-1-benzopyran-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide | 928774-43-0 | C22H26N4O3 |
|
PF-3758309抑制剂 | N-((1S)-2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-4,6-dihydropyrrolo(3,4-C)pyrazole-5(1H)-carboxamide | 898044-15-0 | C25H30N8OS |
|
PF-06305591二水合物 | (2R,3S)-3-amino-3-(5-tert-butyl-1H-benzimidazol-2-yl)-2-methylpropanamide | 1449473-97-5 | C15H22N4O |
|
PF-04620110; 反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并[5,4-f][1,4]氧氮杂卓-6(5H)-基)苯基]环己烷乙酸 | PF-04620110 | 1109276-89-2 | C21H24N4O4 |
|
PF 562271 苯磺酸盐; N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺苯磺酸盐 | N-methyl-N-(3-((2-(2-oxoindolin-5-ylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)pyridin-2-yl)methanesulfonamide benzenesulfonate | 939791-38-5 | C6H6O3S*C21H20F3N7O3S |
|
PF 04217903; 2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-b]吡嗪-6-基]-1H-吡唑-1-基]乙醇 | PF-04217903 | 956905-27-4 | C19H16N8O |
|
PDK1抑制剂 | ethyl 6-(5-(phenylsulfonamido)pyridin-3-yl)imidazo[1,2-a]-pyridine-3-carboxylate | 1276110-06-5 | C21H18N4O4S |
|
PD 173074; N-[2-[[4-(二乙基氨基)丁基]氨基]-6-(3,5-二甲氧基苯基)吡啶并[2,3-d]嘧啶-7-基]-N'-叔丁基脲 | PD 173074 | 219580-11-7 | C28H41N7O3 |
|
PCI 34051; N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺 | N-hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamide | 950762-95-5 | C17H16N2O3 |
|
PALOMID529,一种有效的MTORC1和MTORC2复合物的抑制剂 | palomid 529 | 914913-88-5 | C24H22O6 |
|
P70S6K信号转导抑制剂(LY-2584702FREEBASE) | 4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methyl-1H-imidazol-2-yl]-1-piperidinyl]-1H-pyrazol[3,4-d]pyrimidine | 1082949-67-4 | C21H19F4N7 |
|
P276-00抑制剂 | (+)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]-4H-chromen-4-one hydrochloride | 920113-03-7 | C21H20ClNO5*ClH |
|
P110DELTA抑制剂(PIK-294) | 2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one | 900185-02-6 | C28H23N7O2 |
|
Oprozomib(ONX-0912)抑制剂 | oprozomib | 935888-69-0 | C25H32N4O7S |
|
OSI-027; 反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-f][1,2,4]三嗪-7-基]环己烷羧酸 | OSI-027 | 936890-98-1 | C21H22N6O3 |
|
OSI 420; 2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧]乙醇盐酸盐 | 2-[4-(3-Ethynyl-phenylamino)-7-(2-methoxy-ethoxy)-quinazolin-6-yloxy]-ethanol hydrochloride | 183320-51-6 | C21H21N3O4*ClH |
|
ONX-0914(PR-957)抑制剂 | Onx-0914 (PR-957) | 960374-59-8 | C31H40N4O7 |
|
O-去甲文拉法辛 | O-desmethylvenlafaxine | 93413-62-8 | C16H25NO2 |
|
N,N-二甲基-3-[(1S)-1-(2-吡啶基)乙基]-1H-茚满-2-乙胺马来酸酯 | (S)-(+)-Dimethindene maleate | 136152-65-3 | C24H28N2O4 |
|
N’-[4-[4-[2-[3-[(二甲基氨基)甲基]苯基]-1H-吡咯并[2,3-b]吡啶-4-基]-1-乙基-1H-吡唑-3-基]苯基]-N,N-二甲基脲 | GSK1070916 | 942918-07-2 | C30H33N7O |
|
Nalpha-[(苄氧基)羰基]-N-(4-氟-3-氧代-2-丁烷基)苯丙氨酰胺 | 3-(N-Benzyloxycarbonylphenylalanylamido)-1-fluoro-2-butanone | 197855-65-5 | C21H23FN2O4 |
|
NVP-BHG 712; 4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-d]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺 | NVP-BHG712 | 940310-85-0 | C26H20F3N7O |
|